Skip to Main Content

Paper Details

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.
Nat Cancer
134
2022
PDX, PDXs, PDxO, TNBC, breast cancer, breast cancers, cancer, human, human breast cancer-derived xenograft, metastatic, organoid cultures, patient, triple-negative breast cancer, tumors
Author NameAffiliation
Matthew H BaileyHuntsman Cancer Institute, University of Utah
Matthew H BaileyEccles Institute of Human Genetics, University of Utah
Jeffery M VahrenkampUniversity of Utah
Jeffery M VahrenkampHuntsman Cancer Institute, University of Utah
Lacey E DobroleckiBaylor College of Medicine
Kristofer C BerrettUniversity of Utah
Kristofer C BerrettHuntsman Cancer Institute, University of Utah
Michael T LewisBaylor College of Medicine
Michael T LewisBaylor College of Medicine
Jason GertzUniversity of Utah
Jason GertzHuntsman Cancer Institute, University of Utah
Katherine E VarleyUniversity of Utah
Katherine E VarleyHuntsman Cancer Institute, University of Utah
Bryan E WelmHuntsman Cancer Institute, University of Utah
Bryan E WelmUniversity of Utah
Alana L WelmUniversity of Utah
Alana L WelmHuntsman Cancer Institute, University of Utah
Alana L WelmUniversity of Utah
Alana L WelmHuntsman Cancer Institute, University of Utah
  • 1 - 19

Datasets

Release 1.2